Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability

Abstract

Background:

In multiple sclerosis (MS), various aspects of cognitive function can be detrimentally affected, thus patients’ employment and social functioning is commonly impacted.

Objective:

To analyse income among MS patients in relation to cognitive function, assessed with the Symbol Digit Modalities Test (SDMT).

Methods:

A cross-sectional study including 2080 MS patients was conducted linking national register-based data. Descriptive statistics and a two-part model were used to estimate differences in earnings and social benefits.

Results:

MS patients in the highest SDMT score quartile earned more than twice annually compared to patients in the lowest quartile, whereas patients in the lowest quartile received three times more income through social benefits. The difference in earnings and benefits across the SDMT performance quartiles remained statistically significant after adjusting for various clinical and socio-demographic variables, including physical disability. The corrected prevalence ratios for MS patients in the highest quartile for having income from earnings and benefits were 1.40 (95% confidence interval (CI): 1.29–1.49) and 0.81 (95% CI: 0.71–0.90), respectively, when compared to the patients in the lowest quartile.

Conclusion:

Cognitive function affects the financial situation of MS patients negatively and independently of physical disability. This warrants cognitive testing as a routine measure in health care services for MS patients.

Keywords

Multiple sclerosis cognition cognition disorders socioeconomic factors income salaries and fringe benefits

Get full access to this article

View all access options for this article.

References

Compston

Coles

Multiple sclerosis. Lancet 2008; 372: 1502–1517.

Manouchehrinia

Beiki

Hillert

Clinical course of multiple sclerosis: A nationwide cohort study. Mult Scler 2017; 23: 1488–1495.

Dendrou

Fugger

Friese

MA.

Immunopathology of multiple sclerosis. Nat Rev Immunol 2015; 15: 545–558.

Toosy

Ciccarelli

Thompson

Symptomatic treatment and management of multiple sclerosis. Handb Clin Neurol 2014; 122: 513–562.

Langdon

DW.

Cognition in multiple sclerosis. Curr Opin Neurol 2011; 24: 244–249.

Langdon

Amato

Boringa

et al . Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 2012; 18: 891–898.

Deloire

Bonnet

Salort

et al . How to detect cognitive dysfunction at early stages of multiple sclerosis? Mult Scler 2006; 12: 445–452.

Amato

Portaccio

Goretti

et al . Relevance of cognitive deterioration in early relapsing-remitting MS: A 3-year follow-up study. Mult Scler 2010; 16: 1474–1482.

Strober

Englert

Munschauer

et al . Sensitivity of conventional memory tests in multiple sclerosis: Comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 2009; 15: 1077–1084.

10.

Schiavolin

Leonardi

Giovannetti

et al . Factors related to difficulties with employment in patients with multiple sclerosis: A review of 2002–2011 literature. Int J Rehabil Res 2013; 36: 105–111.

11.

Incerti

Argento

Magistrale

et al . Adverse working events in patients with multiple sclerosis. Neurol Sci 2016; 38: 349–352.

12.

Kavaliunas

Wiberg

Tinghog

et al . Earnings and financial compensation from social security systems correlate strongly with disability for multiple sclerosis patients. PLoS ONE 2015; 10: e0145435.

13.

Amato

Ponziani

Siracusa

et al . Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Archives of Neurology 2001; 58: 1602–1606.

14.

Holmen

Piehl

Hillert

et al . A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. Mult Scler 2011; 17: 708–719.

15.

Matell

Lycke

Svenningsson

et al . Age-dependent effects on the treatment response of natalizumab in MS patients. Mult Scler 2015; 21: 48–56.

16.

The Swedish Neuroregistry (Svenska neuroregister), http://www.neuroreg.se/

17.

Hillert

Stawiarz

The Swedish MS registry – Clinical support tool and scientific resource. Acta Neurol Scand 2015; 132: 11–19.

18.

Integrated database for labour market research: Background facts, labour and education statistics 2011. Stockholm: Statistics Sweden (SCB)

19.

World Health Organization. International statistical classification of diseases and related health problems (10th revision). 2nd ed. Geneva: World Health Organization, 2004.

20.

Belotti

Deb

Mannin

et al . twopm: Two-part models. Stata J 2015; 15: 3–20.

21.

Sveriges Riksbank. http://www.riksbank.se/en/Interest-and-exchange-rates/Annual-aggregate-Exchange-rates/?y=2010&m=12&s=Comma#search

22.

Zhang

KF.

What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 1690–1691.

23.

Bowles

Gintis

Osborne

The determinants of earnings: Skills, preferences, and schooling. Boston, MA: University of Massachusetts, 2000.

24.

Wiberg

Friberg

Stenbeck

et al . Sources and level of income among individuals with multiple sclerosis compared to the general population: A nationwide population-based study. Mult Scler 2015; 21: 1730–1741.

25.

Brenner

Alexanderson

Bjorkenstam

et al . Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study. PLoS ONE 2014; 9: e104165.

26.

Frisell

Forsberg

Nordin

et al . Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis. Mult Scler 2016; 22: 85–93.

27.

Lezak

Howieson

Bigler

et al . Neuropsychological assessment. Oxford: Oxford University Press, 2012.

28.

Potagas

Giogkaraki

Koutsis

et al . Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 2008; 267: 100–106.

29.

Drake

Carra

Allegri

et al . Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis. Neurol India 2006; 54: 370–376.

30.

Bergendal

Fredrikson

Almkvist

Selective decline in information processing in subgroups of multiple sclerosis: An 8-year longitudinal study. Eur Neurol 2007; 57: 193–202.

31.

Berg-Hansen

Celius

EG.

Socio-economic factors and immigrant population studies of multiple sclerosis. Acta Neurol Scand 2015; 132: 37–41.

32.

Lindholm

Burstrom

Diderichsen

Does chronic illness cause adverse social and economic consequences among Swedes?

Scand J Public Health 2001; 29: 63–70.

33.

Strober

Rao

Lee

et al . Cognitive impairment in multiple sclerosis: An 18 year follow-up study. Mult Scler Relat Dis 2014; 3: 473–481.

34.

Landfeldt

Castelo-Branco

Svedbom

et al . Sick leave and disability pension before and after diagnosis of multiple sclerosis. Mult Scler 2016; 22: 1859–1856.

35.

Kavaliunas

Manouchehrinia

Danylaite Karrenbauer

et al . Income in multiple sclerosis patients with different disease phenotypes. PLoS ONE 2017; 12: e0169460.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB